The Pharmacovigilance department has three Units:
- Public health unit
- Clinical practice unit
- Clinical trials unit
Its functions include:
- Communicate safety information to health practitioners and the general public through newsletters, the electronic and print media
- Distribute adverse drug reaction (ADR) forms to all health facilities nationwide
- Confirm receipt of Adverse drug reaction( ADR) including Adverse event following immunization (AEFI) reports and give feedback to reporters, participating institutions and other key stakeholders
- Commit ADR reports to WHO – UMC vigiflow database
- Evaluation of clinical data for registration of new products
- Collaboration with pharmaceutical manufacturers concerning the safety of marketed products
- Conduct hospital inspections
- Conduct Pharmacovigilance Inspections
Contact the department through this email: